Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Zoster Vaccine (CHO Cell)

recombinant zoster vaccine (CHO cell) · MAXVAX Biotechnology Limited Liability Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant Zoster Vaccine (CHO Cell), covering 2024-10-24 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) [Phase 3]

See pricing